Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Year range
1.
Rev. Soc. Bras. Med. Trop ; 42(4): 458-460, July-Aug. 2009.
Article in Portuguese | LILACS | ID: lil-527191

ABSTRACT

Staphylococcus aureus resistente à meticilina foi inicialmente descrito como um típico microrganismo adquirido em infecções nosocomiais. No entanto, nos últimos anos Staphylococcus aureus resistente à meticilina adquirido na comunidade é causa de infecções de pele e tecidos moles, mas infecções graves como pneumonia e sepse podem ocorrer. Este relato descreve um caso de sepse em criança, complicado com pneumonia secundária a lesão em partes moles por Staphylococcus aureus resistente à meticilina adquirido na comunidade no Sul do Brasil. O paciente foi atendido em Unidade de Emergência com história de ferimento provocado por trauma em membro inferior que evoluiu para celulite, pneumonia e sepse.


Methicillin-resistant Staphylococcus aureus was initially described as a typical microorganism acquired in nosocomial infections. However, over recent years, community-acquired methicillin-resistant Staphylococcus aureus has been a cause of skin and soft-tissue infections. Serious infections such as pneumonia and sepsis can also occur. This report describes a case of sepsis in a child that was complicated by pneumonia secondary to soft tissue lesions that were due to community-acquired methicillin-resistant Staphylococcus aureus in southern Brazil. The patient was attended at the Emergency Unit with a history of injury caused by lower-limb trauma that evolved to cellulitis, pneumonia and sepsis.


Subject(s)
Child , Humans , Male , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Pneumonia, Staphylococcal/microbiology , Sepsis/microbiology , Staphylococcal Skin Infections/microbiology , Anti-Bacterial Agents/therapeutic use , Clindamycin/therapeutic use , Community-Acquired Infections/diagnosis , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Gentamicins/therapeutic use , Pneumonia, Staphylococcal/complications , Pneumonia, Staphylococcal/drug therapy , Sepsis/complications , Sepsis/drug therapy , Staphylococcal Skin Infections/complications , Staphylococcal Skin Infections/drug therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL